SCARLETRED

SCARLETRED

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $13M

Overview

SCARLETRED is a certified AI-MedTech company and a leader in standardized mobile skin imaging and analysis. Its core platform, Scarletred®Vision, is a medical device-certified system that uses a proprietary skin patch for calibration and AI to deliver objective, quantitative measurements of skin conditions, supporting numerous clinical scoring systems. The company serves pharmaceutical, cosmetic, and healthcare clients globally with a Software-as-a-Service (SaaS) model, aiming to accelerate clinical research and improve dermatological care.

Dermatology

Technology Platform

Scarletred®Vision: A certified mobile medical device system combining a proprietary calibration skin patch with a smartphone app for standardized 2D/3D/dermoscopic imaging. It uses AI for objective analysis, measuring lesion characteristics (size, color, texture) and automating clinical scores (PASI, EASI, etc.). Includes ARORA® AI for privacy compliance and skin type assessment.

Funding History

2
Total raised:$13M
Series A$10M
Seed$3M

Opportunities

The global shift towards decentralized clinical trials and digital endpoints creates a massive tailwind for SCARLETRED's mobile, regulatory-ready platform.
Expansion into real-world evidence generation and remote patient monitoring for chronic skin diseases offers a significant growth avenue beyond the clinical trial market.

Risk Factors

Key risks include navigating complex and evolving medical device/AI regulations across different regions and facing increasing competition in the digital dermatology space.
Commercial success depends on overcoming inertia and changing established, subjective clinical assessment workflows in pharma and healthcare.

Competitive Landscape

SCARLETRED competes in the digital dermatology and clinical trial endpoint market. Competitors include other specialized digital imaging/analysis startups, large CROs with in-house digital solutions, and generic telehealth platforms. Its key differentiators are its medical device certification, proprietary calibration technology for standardization, and direct integration with pharmaceutical endpoint scoring systems.